Pham Quang X, CEO and Chairman of Cadrenal Therapeutics ($CVKD), sold shares on the open market 11 times over the last year for a total of $312 thousand. His most recent sale was on October 27, 2025. These transactions rank 7,459th out of 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 27, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 1315 | $13.99 | 396,089.0000 | 2,044,033 | 0.33% | 0.06% |
| Oct. 24, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 1129 | $14.03 | 397,404.0000 | 2,044,033 | 0.28% | 0.06% |
| Oct. 13, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 1800 | $14.15 | 398,533.0000 | 2,044,033 | 0.45% | 0.09% |
| Oct. 9, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 1800 | $14.02 | 400,333.0000 | 2,044,033 | 0.45% | 0.09% |
| Oct. 2, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 500 | $14.13 | 402,133.0000 | 2,044,033 | 0.12% | 0.02% |
| Sept. 29, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 419 | $14.01 | 403,514.0000 | 1,961,642 | 0.10% | 0.02% |
| Oct. 1, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 881 | $14.01 | 402,633.0000 | 2,044,033 | 0.22% | 0.04% |
| Sept. 25, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 6790 | $14.09 | 403,933.0000 | 1,961,642 | 1.65% | 0.35% |
| Sept. 24, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 2581 | $13.99 | 410,723.0000 | 1,961,642 | 0.62% | 0.13% |
| Aug. 27, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 3836 | $13.99 | 414,497.0000 | 1,961,642 | 0.92% | 0.20% |
| Aug. 28, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | S | Common Stock | 1193 | $13.99 | 413,304.0000 | 1,961,642 | 0.29% | 0.06% |
| Jan. 23, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | A | Stock Options | 65000 | $0.00 | 65,000.0000 | 1,219,550 | 9999.99% | 5.33% |
| Jan. 23, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | A | Stock Options | 65000 | $0.00 | 65,000.0000 | 1,219,550 | 9999.99% | 5.33% |
| April 10, 2024 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | G | Common Stock | 50000 | $0.00 | 6,275,000.0000 | 1,067,231 | 0.79% | 4.69% |
| Oct. 23, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | G | Common Stock | 85000 | $0.00 | 6,325,000.0000 | 1,026,415 | 1.33% | 8.28% |
| Jan. 18, 2024 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | Chief Executive Officer | A | Stock Options | 150000 | $0.00 | 150,000.0000 | 899,465 | 9999.99% | 16.68% |
| Sept. 5, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.91 | 6,390,000.0000 | 11,722,754 | 0.31% | 0.17% |
| Sept. 5, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.90 | 6,410,000.0000 | 11,722,754 | 0.31% | 0.17% |
| Sept. 1, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.92 | 6,350,000.0000 | 11,722,754 | 0.32% | 0.17% |
| Sept. 1, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.92 | 6,360,000.0000 | 11,722,754 | 0.16% | 0.09% |
| Sept. 1, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.93 | 6,310,000.0000 | 11,722,754 | 0.16% | 0.09% |
| Sept. 1, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.84 | 6,370,000.0000 | 11,722,754 | 0.16% | 0.09% |
| Sept. 1, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.93 | 6,330,000.0000 | 11,722,754 | 0.32% | 0.17% |
| Feb. 10, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Pham Quang X | CEO and Chairman | A | Common Stock | 25000 | $1.94 | 6,300,000.0000 | 7,890,507 | 0.40% | 0.32% |